“Achievement of Treat-to-Target Thresholds With Envudeucitinib, a Selective TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis: Results from STRIDE and OLE”. SKIN The Journal of Cutaneous Medicine 9, no. 6 (November 10, 2025): s650. Accessed May 2, 2026. https://skin.dermsquared.com/skin/article/view/3905.